September 8th, 2014
Selections from Richard Lehman’s Literature Review: September 8th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the PARADIGM-HF trial, sham controls in medical-device trials, the efficacy of β blockers in patients with heart failure and atrial fibrillation, and more.
June 16th, 2014
Selections from Richard Lehman’s Literature Review: June 16th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include statins and physical activity in older men, transitional care interventions to prevent heart-failure readmissions, and more.
October 22nd, 2013
Are Sulfonylureas Dangerous?
Kasia Lipska, MD, MHS
Endocrinologist Kasia Lipska shares her thoughts about a presentation by Craig Currie at this year’s annual meeting of the European Association for the Study of Diabetes.
NEJM Journal Watch — Recent Cardiology Articles- Aprocitentan, a Newly Approved Drug for Resistant Hypertension
- Preventive PCI of Vulnerable Plaques Linked to Fewer Cardiac Events
- News from the ACC Scientific Sessions 2024
- Does the Coronary Sinus Reducer Decrease Ischemia and Angina in Patients with Stable Coronary Disease?
- Plozasiran Reduced Triglyceride Levels in Severe Hypertriglyceridemia